67244-1-Ig

antibody from Proteintech Group

Targeting: TPM4

Western blot (Data presented on provider website)

ELISA (Data presented on provider website)

Antibody Data

Product number

67244-1-Ig

Provider

Proteintech Group

Product name

TPM4 antibody

Antibody type

Monoclonal

Description

TPM4 antibody (Cat. #67244-1-Ig) is a mouse monoclonal antibody that shows reactivity with Human, mouse, rat, pig and has been validated for the following applications: WB,ELISA.

Reactivity

Human, Mouse, Rat, Porcine

Host

Mouse

Conjugate

Unconjugated

Isotype

IgG

Antibody clone number

2E12D12

Vial size

20ul, 150ul

References

Submitted references

Zona pellucida is required for oocyte actin cortex and oocyte-somatic cell interactions during oocyte growth.

Liang S, Xiang W, Quan R, Su J, Lv C, Huang H, Xiao H
Cell death discovery 2026 Apr 20;

---

Hypoxia upregulate TPM4 expression to strengthen epithelial-mesenchymal transition that promotes lymph node metastasis of papillary thyroid cancer.

Li Z, Li F, Jiang X, Li Y, Jia L, Wang X, Liu Y, Jiang R, Zhao K, Pu G, Tian Y, Wang Y, He X
Journal of Cancer 2025;16(10):3216-3234

---

Plasma-Derived Exosomal i-tRF-LeuCAA as Biomarker for Glioma Diagnosis and Promoter of Epithelial-Mesenchymal Transition via TPM4 Regulation.

Liu H, Hu W, Zhang L, Li Z, Liu J, Chen L
CNS neuroscience & therapeutics 2025 Apr;31(4):e70356

---

TPM4 influences the initiation and progression of gastric cancer by modulating ferroptosis via SCD1.

Zhao LL, Liu YJ, Guo QJ, Yan N, Yang J, Han JQ, Xie XH, Luo YS
Clinical and experimental medicine 2025 Apr 11;25(1):115

---

Proteomic changes in the hippocampus of large mammals after total-body low dose radiation.

Iacono D, Hatch K, Murphy EK, Post J, Cole RN, Perl DP, Day RM
PloS one 2024;19(3):e0296903

---

TPM4 condensates glycolytic enzymes and facilitates actin reorganization under hyperosmotic stress.

Yang W, Wang Y, Liu G, Wang Y, Wu C
Cell discovery 2024 Dec 3;10(1):120

---

Association of anti-TPM4 autoantibodies with vasculopathic cutaneous manifestations in juvenile dermatomyositis.

Karasawa R, Yudoh K, Sato T, Tanaka M, Sabbagh SE, Flegel WA, Mammen AL, Jarvis JN, Rider LG, Childhood Myositis Heterogeneity Study Group
Rheumatology (Oxford, England) 2023 Nov 2;62(11):3757-3762